Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADVANCE Study: Assay Development and Validation for Pre-Natal and Obstetric Conditions

NCT07643896 is registered in ClinicalTrials.gov with BillionToOne Inc. as lead sponsor.

NCT NCT07643896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADVANCE Study: Assay Development and Validation for Pre-Natal and Obstetric Conditions
Lead sponsor
BillionToOne Inc.
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2026
Completion date
June 30, 2028
Enrollment
1,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

22q11.2 deletion syndrome, aneuploidy, down syndrome (trisomy 21), pregnant individuals, sex chromosome abnormalities, trisomy 13, trisomy 18